SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-18-001474
Filing Date
2018-02-12
Accepted
2018-02-12 17:26:07
Documents
6
Period of Report
2018-02-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evolus8-k21218.htm 8-K 31646
2 EXHIBIT 3.1 exhibit318-k21218.htm EX-3.1 48830
3 EXHIBIT 3.2 exhibit328-k21218.htm EX-3.2 89367
4 EXHIBIT 99.1 exhibit9918-k21218.htm EX-99.1 9469
5 EXHIBIT 99.2 exhibit9928-k21218.htm EX-99.2 6572
6 evolusa01.jpg GRAPHIC 663077
  Complete submission text file 0001628280-18-001474.txt   1090334
Mailing Address 17901 VON KARMAN AVENUE, SUITE 150 IRVINE CA 92614
Business Address 17901 VON KARMAN AVENUE, SUITE 150 IRVINE CA 92614 (949) 284-4555
Evolus, Inc. (Filer) CIK: 0001570562 (see all company filings)

IRS No.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38381 | Film No.: 18597689
SIC: 2834 Pharmaceutical Preparations